Related Experiment Videos

Multidrug resistance 1 gene expression in Indian patients with gastric carcinoma

S Ramesh1, P Shanthi, K Baba Krishnan

  • 1Department of Pathology, Dr A L Mudaliar Postgraduate Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai 600 113.

Abstract

Insights

Over half of gastric cancer patients exhibit multidrug resistance 1 (MDR1) gene expression, a key factor in chemotherapy resistance. This finding highlights MDR1

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastric carcinoma often shows resistance to chemotherapy.
  • The multidrug resistance 1 (MDR1) gene encodes p-glycoprotein, a drug efflux pump.
  • P-glycoprotein contributes to chemotherapeutic agent resistance.

Purpose of the Study:

  • To investigate the expression of the multidrug resistance 1 (MDR1) gene in gastric carcinoma.
  • To determine the prevalence of MDR1 expression in gastric cancer tissues.

Main Methods:

  • Gastric tissues from 28 gastric cancer patients were analyzed.
  • Immunohistochemistry was employed to detect MDR1 expression.

Main Results:

  • MDR1 expression was observed in 16 out of 28 (57%) gastric cancer cases.
  • Normal gastric mucosa showed perinuclear MDR1 staining in surface epithelial cells.
  • Gastric tumor cells exhibited diffuse cytoplasmic positivity for MDR1.

Conclusions:

  • More than half of the studied gastric carcinoma specimens demonstrated MDR1 gene expression.
  • MDR1 expression is a notable feature in a significant proportion of gastric cancers.

Related Concept Videos